Torrent Pharmaceuticals is in advanced talks with CVC Capital Partners to raise at least $1.2-1.5 billion for its proposed acquisition of rival company Cipla. Torrent is also engaged with Brookfield to raise $1-1.2 billion in mezzanine debt. The company's founders, the Sudhir and Samir Mehta family, are seeking to dilute equity and create a non-disposable undertaking (NDU) using their shares as collateral for loans.
